Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

SOHM, Inc. (SHMN) Employs Strategy For Success In Key Markets

|Includes: SOHM, Inc. (SHMN)

SOHM's mission is to become a global leader in enhancing the health and quality of human life. To this end, the company focuses on developing, manufacturing, and marketing quality branded generic pharmaceuticals, as well as innovative cosmeceuticals and nutraceuticals.

The company recently developed 11 over-the-counter products and is in the process of expanding its cosmeceuticals product pipeline to capture its market share of the rapidly growing skin care industry. November marked the official launch of SOHM's Salic-2® Gel acne treatment, tailing the company's first-quarter launch of its salicylic acid face wash.

SOHM was voted the fastest-growing generics prescription drug manufacturer in 2012 at the 30th All India Conference of National Integrated Medical Association. The award reflects the company's focus of also establishing a secure foothold in the growing generic pharmaceuticals market.

Supportive to the development of this goal is SOHM's successful research and development initiatives and extensive expertise in numerous drug delivery technologies, including liquid, oral, injectable, gel and more. The company's current portfolio includes vitamins and tonics, as well as analgesic, antibiotic, anti-cold, and anti-inflammatory therapies.

In the fall of 2013, SOHM reported that in the first half of the year it had already achieved revenue of more than $1.4 million, surpassing revenue of more than $1.2 million recorded for the full year of 2012.

The company attributes its ongoing improvement to its new skin care product lines to the U.S. market, as well as the release of a unique protein supplement in India. From here on out, SOHM says it is confident that its focused-approach on further growth will serve as a catalyst for its overarching mission of success.

For more information, visit

QualityStocks provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit